FierceHealthcare FierceHealthIT FierceMobileHealthcare FierceHealthPayer
FierceHealthFinance FierceEMR FiercePracticeManagemtn Hospital Impact

Syndicate content

Vaccines news from FierceHealthcare

News

Hospitals mandating healthy employees

Hospitals typically have code-of-conduct policies to regulate how their employees behave professionally. But what happens when hospitals mandate employees' health behaviors, such as smoking and Read more...

Texas A&M joins chase for $1.2B biosecurity program

Texas A&M has created a team of scientists, researchers and clinicians to pursue a $1.2 billion HHS "biosecurity" contract. Winning the bid would mean creating a biosecurity center to develop Read more...

Flu blamed for deaths of Maryland teens

Health officials in Maryland are pushing people to go out and get flu shots after the highly publicized deaths of two local teenagers, reports The Washington Post. Both Zachary Weiland, 15, and Ian Read more...

Study: Mercury in vaccines doesn't hurt kids

A new study has come out that adds to evidence suggesting that a mercury-based preservative previously used in vaccines isn't harmful to children. The study tracks children who, in the early 1990s, Read more...

Google searches for the flu

Last year, a test showed that Google could pinpoint flu outbreaks up to two weeks faster than the CDC's tracking by using search terms. Now Google.org (Google's philanthropic branch) is actively Read more...

ALSO NOTED: Plavix copycat on the rise in Europe; Hospital bills for services to dead patient; and much more...

> Pharma giants Sanofi-Aventis and Bristol-Myers Squibb are preparing to battle a copycat generic to its Plavix brand. Read more...

ALSO NOTED: FDA admits it can't afford to boost foreign inspections; Researchers test anti-smoking vaccine; and much more...

> The FDA has conceded that maybe, just maybe, it will need more money if it's going to do a good job of inspecting foreign drug manufacture sites. Read more...

ALSO NOTED: CO delays raising malpractice award limits; Feds say vaccines might contribute to autism; and much more...

> Colorado has delayed plans to raise limits for judgments in malpractice suits. Report > Big news: It looks like federal authorities Read more...

ALSO NOTED: U.S. adults ignoring valuable vaccines; FL hospitals face CMS hand-slap; and much more...

> It appears that U.S. adults are largely avoiding several new vaccines that can prevent serious illness, according to a new survey. Read more...

ALSO NOTED: Medicare tests PHRs in SC; WellCare in more trouble; and much more...

> Medicare will soon begin testing personal health records with 100,000 beneficiaries in South Carolina. Read more...

Press Releases

Nearly 90 Medicines and Vaccines In Development for HIV/AIDS

WASHINGTON--(BUSINESS WIRE)-- America’s biopharmaceutical research companies are testing 88 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report by the Read more >>

Merck to Present at Goldman Sachs 32nd Annual Healthcare Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Merck's president and chief executive Read more >>

Merial Launches "Outbreak Alert" Program

Building Better Awareness of Equine Disease and the Importance of PreventionDULUTH, Ga., June 1, 2011 /PRNewswire/ -- Supporting horse owners and veterinarians in their efforts to keep their horses Read more >>

Mollen Immunization Clinics to Provide Free Pneumonia Immunizations to Society of St. Vincent de Paul and The Marc Center

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Mollen Immunization Clinics (“Mollen”), one of the largest providers of immunization and other wellness and prevention services in the United States, announced Read more >>

Furiex Acquires Full Exclusive License Rights to Develop and Commercialize JNJ-Q2 (fluoroquinolone)

MORRISVILLE, N.C.--(BUSINESS WIRE)-- Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 Read more >>